Uncovering Institutional Buying In XP Inc (NASDAQ: XP)

Currently, there are 435.72M common shares owned by the public and among those 353.49M shares have been available to trade.

However, the script later moved the day high at 25.60, down -0.44%. The company’s stock has a 5-day price change of -0.67% and -3.68% over the past three months. XP shares are trading -3.68% year to date (YTD), with the 12-month market performance up to 108.55% higher. It has a 12-month low price of $10.72 and touched a high of $27.71 over the same period. XP has an average intraday trading volume of 5.23 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.36%, 0.31%, and 3.61% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of XP Inc (NASDAQ: XP) shares accounts for 48.54% of the company’s 435.72M shares outstanding.

It has a market capitalization of $13.76B and a beta (3y monthly) value of 1.67. The stock’s trailing 12-month PE ratio is 17.47, while the earnings-per-share (ttm) stands at $1.44. The company has a PEG of 1.28 and the debt-to-equity ratio at 3.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.44% over the week and 2.67% over the month.

Earnings per share for the fiscal year are expected to increase by 18.71%, and 17.00% over the next financial year. EPS should shrink at an annualized rate of 13.70% over the next five years, compared to 44.60% over the past 5-year period.

Looking at the support for the XP, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on December 05, 2023, with the firm’s price target at $27-$30. Credit Suisse coverage for the XP Inc (XP) stock in a research note released on July 20, 2023 offered a Neutral rating with a price target of $26. BofA Securities was of a view on June 22, 2023 that the stock is Buy, while Credit Suisse gave the stock Underperform rating on February 17, 2023, issuing a price target of $27- $15. JP Morgan on their part issued Neutral rating on August 11, 2022.

Most Popular

Related Posts